Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Appointed director

Astex Pharmaceuticals, Inc (ASTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2014 SC 13G/A APAX PARTNERS EUROPE MANAGERS LTD reports a 0% stake in Astex Pharmaceuticals, Inc.
10/16/2013 4 LACK WALTER J (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Unknown transaction of 457,500 shares @ $0
Disposed/sold 22,500 options to buy @ $7.79, valued at $175.3k
Disposed/sold 30,000 options to buy @ $5.89, valued at $176.7k
Disposed/sold 45,000 options to buy @ $2.1, valued at $94.5k
Disposed/sold 45,000 options to buy @ $4.6, valued at $207k
10/16/2013 4 Kola Ismail (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Disposed/sold 26,192 options to buy @ $0.92, valued at $24.1k
Disposed/sold 50,000 options to buy @ $2.94, valued at $147k
Disposed/sold 20,000 options to buy @ $2.1, valued at $42k
Disposed/sold 20,000 options to buy @ $4.6, valued at $92k
10/16/2013 4 Haines Timothy (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Disposed/sold 50,000 options to buy @ $2.94, valued at $147k
Disposed/sold 32,500 options to buy @ $2.1, valued at $68.3k
Disposed/sold 32,500 options to buy @ $4.6, valued at $149.5k
10/16/2013 4 Goldberg Allan R (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Disposed/sold 50,000 options to buy @ $4.89, valued at $244.5k
Disposed/sold 7,500 options to buy @ $4.84, valued at $36.3k
Disposed/sold 10,000 options to buy @ $3.97, valued at $39.7k
Disposed/sold 8,889 options to buy @ $3.65, valued at $32.4k
Disposed/sold 10,000 options to buy @ $5.89, valued at $58.9k
Disposed/sold 8,621 options to buy @ $4.03, valued at $34.7k
Disposed/sold 10,000 options to buy @ $2.01, valued at $20.1k
Disposed/sold 12,658 options to buy @ $1.89, valued at $23.9k
Disposed/sold 10,000 options to buy @ $1.98, valued at $19.8k
Disposed/sold 10,204 options to buy @ $2.7, valued at $27.6k
Disposed/sold 7,500 options to buy @ $3.26, valued at $24.5k
10/16/2013 4 GIRARDI THOMAS V (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Unknown transaction of 348,500 shares @ $0
Disposed/sold 22,500 options to buy @ $7.79, valued at $175.3k
Disposed/sold 10,000 options to buy @ $5.88, valued at $58.8k
Disposed/sold 22,500 options to buy @ $4.84, valued at $108.9k
Disposed/sold 30,000 options to buy @ $3.97, valued at $119.1k
Disposed/sold 30,000 options to buy @ $5.89, valued at $176.7k
Disposed/sold 30,000 options to buy @ $2.01, valued at $60.3k
Disposed/sold 30,000 options to buy @ $1.98, valued at $59.4k
Disposed/sold 35,000 options to buy @ $2.14, valued at $74.9k
Disposed/sold 35,000 options to buy @ $2.92, valued at $102.2k
Disposed/sold 45,000 options to buy @ $2.1, valued at $94.5k
10/16/2013 4 Fellner Peter (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Disposed/sold 50,000 options to buy @ $2.94, valued at $147k
Disposed/sold 20,000 options to buy @ $2.1, valued at $42k
Disposed/sold 20,000 options to buy @ $4.6, valued at $92k
10/16/2013 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Disposed/sold 15,000 options to buy @ $7.79, valued at $116.9k
Disposed/sold 10,000 options to buy @ $5.88, valued at $58.8k
Disposed/sold 15,000 options to buy @ $4.84, valued at $72.6k
Disposed/sold 20,000 options to buy @ $3.97, valued at $79.4k
Disposed/sold 20,000 options to buy @ $5.89, valued at $117.8k
Disposed/sold 7,500 options to buy @ $3.26, valued at $24.5k
Disposed/sold 35,000 options to buy @ $2.14, valued at $74.9k
Disposed/sold 25,000 options to buy @ $2.92, valued at $73k
Disposed/sold 833 options to buy @ $2.92, valued at $2.4k
Disposed/sold 32,500 options to buy @ $4.6, valued at $149.5k
10/16/2013 4 MOLKENTIN MICHAEL (CFO) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Unknown transaction of 28,874 shares @ $0
Disposed/sold 25,000 options to buy @ $4.89, valued at $122.3k
Disposed/sold 60,000 options to buy @ $5.1, valued at $306k
Disposed/sold 42,750 options to buy @ $5.32, valued at $227.4k
Disposed/sold 96,000 options to buy @ $2.35, valued at $225.6k
Disposed/sold 67,500 options to buy @ $1.65, valued at $111.4k
Disposed/sold 110,000 options to buy @ $3.23, valued at $355.3k
Disposed/sold 150,000 options to buy @ $2.78, valued at $417k
Disposed/sold 160,000 options to buy @ $1.89, valued at $302.4k
Disposed/sold 160,000 options to buy @ $2.71, valued at $433.6k
10/16/2013 4 Buckland Martin (Chief Business Officer) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Unknown transaction of 5,963 shares @ $0
Disposed/sold 52,384 options to buy @ $0.7, valued at $36.7k
Disposed/sold 26,192 options to buy @ $0.84, valued at $22k
Disposed/sold 19,644 options to buy @ $0.87, valued at $17.1k
Disposed/sold 26,192 options to buy @ $0.73, valued at $19.1k
Disposed/sold 32,085 options to buy @ $0.79, valued at $25.3k
Disposed/sold 98,220 options to buy @ $0.92, valued at $90.4k
Disposed/sold 150,000 options to buy @ $2.21, valued at $331.5k
Disposed/sold 180,000 options to buy @ $1.89, valued at $340.2k
Disposed/sold 180,000 options to buy @ $2.71, valued at $487.8k
10/16/2013 4 AZAB MOHAMMAD (Chief Medical Officer) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Unknown transaction of 8,753 shares @ $0
Disposed/sold 260,000 options to buy @ $2.58, valued at $670.8k
Disposed/sold 60,000 options to buy @ $3.23, valued at $193.8k
Disposed/sold 280,000 options to buy @ $2.78, valued at $778.4k
Disposed/sold 200,000 options to buy @ $1.89, valued at $378k
Disposed/sold 300,000 options to buy @ $2.71, valued at $813k
10/16/2013 4 Jhoti Harren (President) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Unknown transaction of 45,163 shares @ $0
Unknown transaction of 16,084 shares @ $0
Disposed/sold 8,792 options to buy @ $0.84, valued at $7.4k
Disposed/sold 26,192 options to buy @ $0.87, valued at $22.8k
Disposed/sold 65,480 options to buy @ $0.68, valued at $44.5k
Disposed/sold 38,633 options to buy @ $0.79, valued at $30.5k
Disposed/sold 111,316 options to buy @ $0.92, valued at $102.4k
Disposed/sold 300,000 options to buy @ $2.21, valued at $663k
Disposed/sold 210,000 options to buy @ $1.89, valued at $396.9k
Disposed/sold 210,000 options to buy @ $2.71, valued at $569.1k
10/16/2013 4 MANUSO JAMES S J (CEO) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Unknown transaction of 13,900 shares @ $0
Unknown transaction of 70 shares @ $0
Disposed/sold 250,000 options to buy @ $6.1, valued at $1.5M
Disposed/sold 250,000 options to buy @ $5.03, valued at $1.3M
Disposed/sold 200,000 options to buy @ $4.87, valued at $974k
Disposed/sold 360,000 options to buy @ $5.06, valued at $1.8M
Disposed/sold 1,000,000 options to buy @ $5.06, valued at $5.1M
Disposed/sold 360,000 options to buy @ $3.6, valued at $1.3M
Disposed/sold 360,000 options to buy @ $2, valued at $720k
Disposed/sold 1,200,000 options to buy @ $1.76, valued at $2.1M
Disposed/sold 360,000 options to buy @ $3.12, valued at $1.1M
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Astex Pharmaceuticals, Inc., effective as of October 11, 2013",
"Bylaws of Astex Pharmaceuticals, Inc., effective as of October 11, 2013"
10/11/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/11/2013 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/10/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/09/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/08/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/08/2013 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/07/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/07/2013 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
09/06/2013 4 MANUSO JAMES S J (CEO) has filed a Form 4 on Astex Pharmaceuticals, Inc
Txns: Exercised 7,500 options to buy @ $5.69, valued at $42.7k
09/05/2013 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
09/05/2013 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
09/05/2013 8-K Quarterly results
08/09/2013 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans
08/09/2013 10-Q Quarterly Report for the period ended June 30, 2013
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy